L'Entourage d'Emily annonce l'ajout de David M. Bedwell, Ph.D., à son conseil consultatif scientifique

Dr. Bedwell joins seven other highly respected and experienced researchers, clinicians, and health industry leaders to provide guidance on strategic research priorities for the organization

David M. Bedwell, PhD, joins the Scientific Advisory Board for Emily’s Entourage

Lower Merion, PA — Sept. 12, 2022 — Emily’s Entourage (EE), an innovative 501(c)3 foundation that accelerates research for new treatments and a cure for the final 10% of people with cystic fibrosis (CF), including those with nonsense mutations, today announced the addition of David M. Bedwell, PhD, to its Scientific Advisory Board (SAB). EE’s SAB brings together top researchers, clinicians, and health industry leaders, including some of the most respected names in CF research and care.

Dr. Bedwell is the James C. and Elizabeth T. Lee Endowed Chair of Biochemistry and is professor and chair of the Department of Biochemistry and Molecular Genetics in the Heersink School of Medicine at the University of Alabama at Birmingham (UAB).

“Dr. Bedwell brings decades of expertise and leadership in key areas in cystic fibrosis research, as well as a palpable passion for the CF community at large,” said Chandra Ghose, PhD, Chief Scientific Officer at Emily’s Entourage. “We are thrilled to have him as an invaluable member of our SAB as we continue our work on expediting the research and development of therapeutics for patients with CF who do not benefit from current mutation-targeted treatments.”

Dr. Bedwell serves as the co-director of the UAB Structural Biology Program and as the interim director of the Gregory Fleming James Cystic Fibrosis Research Center. He is also an editorial board member for the Journal of Biological Chemistry. 

“I’m delighted to be given the opportunity to join the team at Emily’s Entourage,” said Dr. Bedwell. “I have been impressed with their past accomplishments and I hope I can help them achieve many more in the coming years.”

Dr. Bedwell sits on the Conseil consultatif scientifique alongside the following members:

• Jennifer Bomberger, PhD
• Kevin Foskett, PhD (président du conseil d'administration)
• Denis Hadjiliadis, MD
• Batsheva Kerem, PhD
• Jennifer Taylor-Cousar, MD, MSCS, ATSF
• Ted J. Torphy, PhD
• David B. Weiner, PhD

###

À propos de l'entourage d'Emily
L'Entourage d'Emily est une fondation innovante de type 501(c)3 qui accélère la recherche de nouveaux traitements et d'un remède pour les mutations du non-sens de la mucoviscidose, une maladie génétique mortelle qui affecte principalement les poumons et le système digestif. Depuis 2011, Emily's Entourage a octroyé des millions de dollars en subventions de recherche, lancé une société de thérapie génique de la fibrose kystique, développé un registre de patients et un programme de jumelage d'essais cliniques pour accélérer le recrutement d'essais cliniques, et mené des efforts à l'échelle mondiale pour stimuler la recherche à fort impact et le développement de médicaments. L'organisation a fait l'objet d'articles dans les médias nationaux, notamment dans le New York Times, STAT, CNN et People. Pour en savoir plus emilysentourage.org. 

Contact presse
Ashling Knight
Directeur du marketing et de la communication
L'entourage d'Emily
ashling@emilysentourage.org